Compounds and methods for treating bacterial infections

Abstract

The present invention encompasses compounds and methods for treating urinary tract infections.

1 - 10 . (canceled) 
     
     
         11 . A compound of Formula (I): 
       
         
           
           
               
               
           
         
         wherein: 
         X is selected from the group consisting of hydrogen, OR 2 , SR 2 , and NR z ; 
         Z is selected from the group consisting of O, S, CR 3  and NR 4 ; 
         Y is selected from the group consisting of oxygen, sulfur, CR 3 , NR 4 , —N(R 5 )CO—, —CH 2 N(R 5 )—, —CH 2 N(R 5 )CO—, CO 2 , SO 2 , —CH 2 O—, —CH 2 S—, CO, —CON(R 5 )—, —SO 2 N(R 5 )—, —O(CH 2 ) n —, —S(CH 2 ) n —, —N(CH 2 ) n —, —(CH 2 ) n —, NR 5 , and an optionally substituted alkyl, alkene, alkyne, or heterocycle; 
         R 2  is independently selected from the group consisting of hydrogen, COR x , CONR x , hydrocarbyl, and substituted hydrocarbyl; 
         R 3 , R 4 , R 5  are independently selected from the group consisting of hydrogen, hydrocarbyl, and substituted hydrocarbyl; 
         R z  is independently selected from the group consisting of hydrogen hydrocarbyl, substituted hydrocarbyl, —COR x , —CONR x R x SO 2 R x , and —CO 2 R x ; 
         R x  is independently selected from the group consisting of hydrogen, NR 4 R 5 , and an optionally substituted alkyl, cycloalkyl, heterocycle, or aryl; 
         n is an integer from 1 to 10; and 
         R 1  is Formula (IV): 
       
       
         
           
           
               
               
           
         
         wherein: 
         A is independently selected from the group consisting of C, CR 6  and N; 
         R 6  is independently selected from the group consisting of hydrogen, hydrocarbyl, and substituted hydrocarbyl; 
         R 11  and R 12  are independently selected from the group consisting of OR 15 , —NR 15 R 16 , —NR 15 COR 16 , —NR 15 CO 2 R 16 , —NR 15 CONR 16 , —NR 15 SO 2 R 16 , —COR 15 , —SO 2 R 15 , nitro, cyano, halogen, aryl, heterocycle, —COOR 15 , —CONR 16 R 17 , —SO 2 NR 18 R 19 , alkenyl, alkynyl, hydrocarbyl, and substituted hydrocarbyl; 
         R 15 , R 16 , R 17 , R 18 , R 19  are independently selected from the group consisting of hydrogen, hydrocarbyl, substituted hydrocarbyl, aryl, and heterocycle, and R 16  and R 17  together can optionally form a ring, and R 18  and R 19  together can optionally form a ring; and 
         (a) of R 11  is the integer 1 and (a) of R 12  is either the integer 1 or the integer 2. 
       
     
     
         12 . The compound of claim  1 , wherein X is OR 2  and Z is O. 
     
     
         13 . The compound of claim  1 , wherein X is OR 2 ; Z is O; R 11  is selected from the group consisting of —OR 15 , methyl, halogen, CO 2 Me, hydrocarbyl, and substituted hydrocarbyl. 
     
     
         14 . The compound of  claim 14 , wherein Formula (IV) is: 
       
         
           
           
               
               
           
         
       
     
     
         15 . The compound of claim  1 , wherein X is OR 2 ; Z is O; Y is selected from the group consisting of oxygen, sulfur, CR 3 , NR 4 , —N(R 5 )CO—, —CH 2 N(R 5 )—, —CH 2 O—, —CON(R 5 )—, —CH 2 N(R 5 )CO—, —(CH 2 ) n — and an optionally substituted alkyl. 
     
     
         16 . The compound of claim  1 , wherein X is OR 2 ; Z is O; Y is selected from the group consisting of oxygen, sulfur, NH, —CH 2 O—, —CONH, —CH 2 NHCO—, —(CH 2 ) n — and an optionally substituted alkyl. 
     
     
         17 . The compound of  claim 15 , wherein Y is selected from the group consisting of oxygen, sulfur, NH, —(CH 2 ) n — and an optionally substituted alkyl; and R 12  is selected from the group consisting of —COOR 15  and —CONR 16 R 17 . 
     
     
         18 . The compound of claim  1 , wherein X is OR 2 ; Z is O; Y is selected from the group consisting of oxygen and an optionally substituted alkyl; Formula (IV) is: 
       
         
           
           
               
               
           
         
         R 11  is selected from the group consisting of —OR 15 , methyl, halogen, CO 2 Me, and hydrocarbyl; and R 12  is selected from the group consisting of —COOR 15  and —CONR 16 R 17 . 
       
     
     
         19 . A method of treating a urinary tract infection, the method comprising administering a compound of claim  1  to a subject in need thereof. 
     
     
         20 . The method of  claim 19 , wherein the subject is further administered a bactericidal composition. 
     
     
         21 . A method of reducing the resistance of a bacterium to a bactericidal compound, the method comprising administering a compound of claim  1  to a subject in need thereof.